Bitcoin's Narrative as a Store of Value Gathers Momentum as Countries Reduce USD Allocation of their FX Reserves

FX Reserves Allocated to USD-Assets have Fallen by 5% Since 2018 Mr. Hansen was responding to another Tweet that elaborated on the shift by countries worldwide away from the US dollar as a reserve currency. The analysis pointed out that according to J.P Morgan, the proportion of foreign reserves allocated to USD assets had declined by 5% since 2018. Additionally, […]

Read more

US Foods Adds 4% On Improved Q1 Results, Above Street View

Shares of foodservice distributor US Foods Holding Corp. (USFD) are up more than 4% Thursday morning after reporting preliminary first-quarter results, better than analysts’ view. Net loss for the quarter narrowed to $16 million or $0.07 per share from $39 million or $0.18 per share loss a year ago. Excluding one-time items, earning were $0.36 per share, that beat the […]

Read more

Cryptos Tank As Macros Hurt; Bitcoin Drops Below $39k

Cryptocurrencies plunged again early on Monday amidst an uneasy tryst with the macro-economic conditions, as red-hot inflation and surging bond yields stoked worries of a global recession. Bitcoin dropped below the psychological $39k level, touching $38,696.19, a level last touched in the middle of March 2022. Cryptocurrency market capitalization is at $1.83 trillion, versus $1.89 trillion a week ago. Another […]

Read more

Bitcoin ($BTC) Price to See ‘Massive Rally’ in 6-12 Months, Says Pantera Capital CEO

Cryptocurrency investment firm Pantera Capital CEO and co-CIO Dan Morehead has revealed he believes that as the cryptocurrency market becomes broader and more valuable the “amplitude of price swings will moderate,” although he sees a “massive rally” in the next 6-12 months. In a note shared with investors, Morehead wrote that while Bitcoin ($BTC) has had two major bear markets […]

Read more

ATyr Pharma Adds 7% On Receiving Orphan Drug Status For Its Lead Drug Candidate

Shares of aTyr Pharma, Inc. (LIFE) are rising more than 7% in the morning trade on Wednesday after the company received orphan drug designation from the FDA for its lead drug candidate, efzofitimod, for the treatment of systemic sclerosis. Orphan drug designation provides certain benefits, including the potential for seven years of market exclusivity following regulatory approval, exemption from FDA […]

Read more
1 70 71 72 73 74 192